Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Drug Discovery Today. Technologies
|
May 23, 2014
Genetic barrier and variant fitness in hepatitis C as critical parameters for drug resistance development
Christoph Welsch
Gastroenterology
|
April 28, 2012
Will interferon-free regimens prevail?
Christoph Welsch, Stefan Zeuzem
Gastroenterology
|
November 3, 2009
RNA-binding activity of hepatitis C virus NS4B: a novel target for small molecule inhibitors
Christoph Welsch, Stefan Zeuzem
Seminars in Liver Disease
|
August 23, 2003
Pharmacokinetics of peginterferons
Stefan Zeuzem, Christoph Welsch, Eva Herrmann
Clinics in Liver Disease
|
July 16, 2008
Novel hepatitis C drugs in current trials
Bernd Kronenberger, Christoph Welsch, Nicole Forestier, et al.
Pathogens (Basel, Switzerland)
|
January 21, 2022
Regulatory Role of Phospholipids in Hepatitis C Virus Replication and Protein Function
Anna V Bulankina, Rebecca M Richter, Christoph Welsch
Gut
|
April 17, 2012
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
Christoph Welsch, Arun Jesudian, Stefan Zeuzem, et al.
Journal of Virology
|
October 11, 2019
Palmitoylation of Hepatitis C Virus NS2 Regulates Its Subcellular Localization and NS2-NS3 Autocleavage
Ming-Jhan Wu, Saravanabalaji Shanmugam, Christoph Welsch, et al.
Journal of Virology
|
April 29, 2011
Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III
Seungtaek Kim, Christoph Welsch, MinKyung Yi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 14, 2024
Graph-Theoretical Prediction and Analysis of Biologically Relevant Substructures in an Open and Closed Conformation of Respiratory Complex I
Florian J Gisdon, Jörg Ackermann, Christoph Welsch, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Drug Discovery Today. Technologies
|
May 23, 2014
Genetic barrier and variant fitness in hepatitis C as critical parameters for drug resistance development
Christoph Welsch
Gastroenterology
|
April 28, 2012
Will interferon-free regimens prevail?
Christoph Welsch, Stefan Zeuzem
Gastroenterology
|
November 3, 2009
RNA-binding activity of hepatitis C virus NS4B: a novel target for small molecule inhibitors
Christoph Welsch, Stefan Zeuzem
Seminars in Liver Disease
|
August 23, 2003
Pharmacokinetics of peginterferons
Stefan Zeuzem, Christoph Welsch, Eva Herrmann
Clinics in Liver Disease
|
July 16, 2008
Novel hepatitis C drugs in current trials
Bernd Kronenberger, Christoph Welsch, Nicole Forestier, et al.
Pathogens (Basel, Switzerland)
|
January 21, 2022
Regulatory Role of Phospholipids in Hepatitis C Virus Replication and Protein Function
Anna V Bulankina, Rebecca M Richter, Christoph Welsch
Gut
|
April 17, 2012
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
Christoph Welsch, Arun Jesudian, Stefan Zeuzem, et al.
Journal of Virology
|
October 11, 2019
Palmitoylation of Hepatitis C Virus NS2 Regulates Its Subcellular Localization and NS2-NS3 Autocleavage
Ming-Jhan Wu, Saravanabalaji Shanmugam, Christoph Welsch, et al.
Journal of Virology
|
April 29, 2011
Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III
Seungtaek Kim, Christoph Welsch, MinKyung Yi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 14, 2024
Graph-Theoretical Prediction and Analysis of Biologically Relevant Substructures in an Open and Closed Conformation of Respiratory Complex I
Florian J Gisdon, Jörg Ackermann, Christoph Welsch, et al.
Page
of 10